Dr. Larry B. Goldstein named associate dean for clinical research

The University of Kentucky College of Medicine has developed into a research powerhouse, helping deliver solutions for Kentucky’s most urgent health needs.

Clinical research is vital in bringing important discoveries from the laboratory into the clinic to improve patient treatment. To continue strengthening its research capabilities, the college is excited to share its selection to fill a newly created position — associate dean for clinical research.

Larry B. Goldstein, MD, chair of neurology and co-director of the UK Kentucky Neuroscience Institute, has been chosen to take on this role. 

As associate dean, Goldstein will oversee clinical research infrastructure and space, partner with clinical chairs to establish and expand on research goals, develop clinical research mentorship opportunities and enhance pipeline programs and provide support and guidance to clinical research faculty, staff and learners.

Goldstein’s leadership of a thriving department of neurology has demonstrated his ability to excel in this new role. Prioritizing diversity and inclusion, he has established an inclusive framework for his department. Goldstein has also focused attention on the health and well-being of his faculty, staff and learners by addressing the need for wellness opportunities.

As a clinician and scientist, Goldstein’s work in stroke-related clinical care, research and education is internationally recognized. He has served in multiple national leadership positions and has received multiple awards reflecting his success.  Goldstein has extensive experience leading and participating in NIH and industry sponsored clinical trials and has served on several FDA advisory panels.

Along with serving as chair of his department and co-director of KNI, Goldstein is the Ruth L. Works Professor, co-director of the Neuroscience Research Priority Area and interim director of the UK-Norton Healthcare Stroke Care Network. Goldstein will continue to serve in these key leadership roles for the department, KNI and RPA.

Goldstein is also a co-principal investigator of the Alliance for Reduction of Diabetes Associated Microvascular Dysfunction (ADAM), a team within the college’s Alliance Research Initiative aiming to discover new treatments of disorders involving this condition. He is the principal investigator for the newly established Kentucky CDC National Acute Stroke Project Award, aimed at improving stroke prevention and care throughout Kentucky.

In spring of 2021, Goldstein was selected to serve on the board of directors for The American Academy of Neurology.

Goldstein earned his medical degree from Mount Sinai School of Medicine and completed his neurology residency at Mount Sinai Medical Center. He completed a research fellowship in cerebrovascular disease at Duke University.